Oncology PracticeThe push for smaller, smarter cancer trialsMarch 17, 2014Breast CancerGastroenterologyGenitourinary CancerGynecologic CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung Cancer
Oncology PracticeVemurafenib improved survival in BRAF mutation–positive metastatic melanomaMarch 11, 2014Melanoma
Oncology PracticeAggressive secondary squamous carcinoma appeared during BRAF inhibitor targeted therapy February 26, 2014MelanomaNonmelanoma Skin Cancer
The Journal of Community and Supportive OncologyDabrafenib in advanced melanoma with BRAF V600E mutationFebruary 20, 2014Melanoma
The Journal of Community and Supportive OncologyCurrent options and future directions in the systemic treatment of metastatic melanomaFebruary 4, 2014MelanomaPatient & Survivor Care
Oncology PracticeIBD linked to increased risk of certain cancersFebruary 1, 2014GastroenterologyMelanomaGastrointestinal Cancer
Oncology PracticePoor accrual halts one in five cancer clinical trialsJanuary 30, 2014Genitourinary CancerMelanoma
Oncology PracticeSeemingly pan-negative melanomas may be sensitive to MEK inhibitorDecember 17, 2013Melanoma
The Journal of Community and Supportive OncologyKey issues in the management of gastrointestinal immune-related adverse events associated with ipilimumab administrationDecember 12, 2013MelanomaPatient & Survivor Care
The Journal of Community and Supportive OncologyAnti-PD-1 antibodies in melanomaDecember 12, 2013Melanoma
